TAK logo

TAK EBITDA Margin

Latest reported31.90%
TAK Quarterly EBITDA Margin (60.35% → 31.90%)
High-resolution chart · PNG

TAK ebitda margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) EBITDA Margin — Quarterly
Period endingEBITDA Margin
31.9045%
13.8948%
37.3207%
26.6261%
39.7063%
17.208%
16.8694%
32.3355%
32.1621%
32.6183%
23.1308%
13.8759%
34.5837%
20.8682%
33.1751%
28.552%
37.9679%
15.0474%
29.5332%
28.618%
46.0186%
25.297%
33.8082%
23.7341%
39.7486%
7.0002%
24.8338%
23.8602%
20.1729%
11.7718%
21.6665%
26.7981%
32.7274%
-5.5277%
28.1091%
18.123%
56.6937%
-1.925%
21.8009%
17.6559%
45.3304%
4.6573%
21.9551%
23.361%
22.0742%
-56.4829%
33.7826%
23.3921%
27.099%
20.4607%
28.787%
28.1585%
24.1476%
4.0948%
21.3361%
26.6528%
19.2098%
-94.2537%
49.6391%
57.6096%
61.8954%
-74.2969%
66.0677%
70.2786%
67.8326%
-77.8743%
67.7387%
70.9626%
73.909%
-77.2713%
75.3994%
60.3502%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.